Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine and DBT for Borderline Personality Disorder
NCT00533117Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2001
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluoxetine in borderline personality disorder (BPD) (4 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Suicide Attempts. Started Mar 2001; status: completed.
02
Drugs
fluoxetine
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT00533117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533117.